Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Auditor

AKEBIA THERAPEUTICS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2025-03-13: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2024-03-14: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2023-08-28: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31Ernst & Young LLP42Boston, MassachusettsYes
2025-03-132024-12-31Ernst & Young LLP42Boston, MassachusettsYes
2024-03-142023-12-31Ernst & Young LLP42Boston, MassachusettsYes
2023-08-282022-12-31Ernst & Young LLP42Boston, MassachusettsYes
2023-03-102022-12-31Ernst & Young LLP42Boston, MassachusettsYes
2022-03-012021-12-31Ernst & Young LLP42Boston, MassachusettsYes
2021-02-252020-12-31Ernst & Young LLPBoston, MassachusettsYes
2020-03-122019-12-31Ernst & Young LLPBoston, Massachusetts
2019-03-262018-12-31Ernst & Young LLPBoston, Massachusetts
2018-03-122017-12-31Ernst & Young LLPBoston, Massachusetts
2017-03-062016-12-31Ernst & Young LLPBoston, Massachusetts
2016-03-142015-12-31Ernst & Young LLPBoston, Massachusetts
2015-03-042014-12-31Ernst & Young LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33